Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

28. Matching and Differential Therapies 661Results from the Epidemiologic Catchment Area (ECA) study. JAMA, 264, 2511–2518.Rohsenow, D. J., Monti, P. M., Martin, R. A., Michalec, E., & Abrams, D. B. (2000).Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes.J Consult Clin Psychol, 68, 515–520.Rounsaville, B. J. (1995). Can psychotherapy rescue naltrexone treatment of opioidaddiction? In L. S. Onken & J. D. Blaine (Eds.), Potentiating the efficacy of medications:Integrating psychosocial therapies with pharmacotherapies in the treatment of drugdependence (pp. 37–52). Rockville, MD: National Institute on Drug Abuse.Rounsaville, B. J. (2004). Treatment of cocaine dependence and depression. Biol Psych,15, 803–809.Rounsaville, B. J., & Carroll, K. M. (1997). Individual psychotherapy for drug abusers.In J. H. Lowinsohn, P. Ruiz, & R. B. Miller (Eds.), Comprehensive textbook of substanceabuse (3rd ed., pp. 430–439). New York: Williams & Wilkins.Rounsaville, B. J., Gawin, F. H., & Kleber, H. D. (1985). Interpersonal psychotherapyadapted for ambulatory cocaine abusers. Am J Drug Alcohol Abuse, 11, 171–191.Rounsaville, B. J., & Kosten, T. R. (2000). Treatment for opioid dependence: Qualityand access. JAMA, 283(10), 1337–1339.Schottenfeld, R. S., Pakes, J. R., Oliveto, A., Ziedonis, D., & Kosten, T. R. (1997).Buprenorphine vs. methadone maintenance treatment for concurrent opioiddependence and cocaine abuse. Arch Gen Psychiatry, 54, 713–720.Silverman, K. (1999). Voucher-based reinforcement of cocaine abstinence in treatmentresistantmethadone patients: Effects of reinforcer magnitude. Psychopharmacology(Berl), 146(2), 128–138.Silverman, K., Higgins, S. T., Brooner, R. K., Montoya, I. D., Cone, E. J., Schuster, C.R., et al. (1996). Sustained cocaine abstinence in methadone maintenancepatients through voucher-based reinforcement therapy. Arch Gen Psychiatry, 53,409–415.Silverman, K., Svikis, D. S., Wong, C. J., Hampton, J., Stitzer, M. L., & Bigelow, G. E.(2002). A reinforcement-based therapeutic workplace for the treatment of drugabuse: Three year abstinence outcomes. Exp Clin Psychopharmacol, 10, 228–240.Silverman, K., Wong, C. J., Umbricht-Schneiter, A., Montoya, I. D., Schuster, C. R., &Preston, K. L. (1998). Broad beneficial effects of cocaine abstinence reinforcementamong methadone patients. J Consult Clin Psychol, 66, 811–824.Simpson, D. D., Joe, G. W., & Brown, B. S. (1997). Treatment retention and follow-upoutcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol AddictBehav, 11, 294–307.Stephens, R., Roffman, R. A., & Curtin, L. (2000). Comparison of extended versus brieftreatments for marijuana use. J Consult Clin Psychol, 68, 898–908.Stitzer, M. L., Iguchi, M. Y., Kidorf, M., & Bigelow, G. E. (1993). Contingency managementin methadone treatment: The case for positive incentives. In L. S. Onken, J.D. Blaine, & J. J. Boren (Eds.), Behavioral treatments for drug abuse and dependence(pp. 19–36). Rockville, MD: National Institute on Drug Abuse.Strain, E. C., Preston, K. L., Liebson, I. A., & Bigelow, G. E. (1995). Buprenorphineeffects in methadone-maintained volunteers: Effects at two hours after methadone.J Pharmacol Exp Ther, 272, 628–638.Svikis, D. S., Haug, N. A., & Stitzer, M. L. (1997). Attendance incentives for outpa-